The efficacy of 40 mg versus dose de-escalation to less than 40 mg of afatinib (Giotrif) as the first-line therapy for patients with primary lung adenocarcinoma harboring favorable...

por Liu, Chien-Ying, Wang, Chih-Liang, Li, Shih-Hong, Hsu, Ping-Chih, Chen, Chih-Hung, Lin, Ting-Yu, Kuo, Chih-Hsi, Fang, Yueh-Fu, Ko, How-Wen, Yu, Chih-Teng, Yang, Tai-Yun, Yang, Cheng-Ta
Publicado 2017